← FDA Drug Approvals (Drugs@FDA)

ICATIBANT ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-07-15

Drug application

FDA Application #

ANDA210118

Application type

Abbreviated New Drug Application (Generic)

Brand name

ICATIBANT ACETATE

Generic name

ICATIBANT

Active ingredients

ICATIBANT ACETATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2019-07-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown